UOC
MXIM

UBS O'Connor’s Maxim Integrated Products MXIM Stock Holding History

UBS O'Connor’s Portfolio MXIM Stock Details MXIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,064,116
Closed -$850M – 1053
2021
Q2 		$850M Buy
8,064,116
+5,361,951
+198% +$525M 7.58% 1
2021
Q1 		$247M Buy
2,702,165
+579,044
+27% +$53.1M 3.56% 5
2020
Q4 		$188M Buy
2,123,121
+393,347
+23% +$31M 3.84% 5
2020
Q3 		$117M Buy
+1,729,774
New +$117M 2.97% 7
2015
Q4 		– Sell
-92,696
Closed -$3.1M – 586
2015
Q3 		$3.1M Buy
92,696
+2,696
+3% +$89.3K 0.03% 326
2015
Q2 		$3.11M Buy
+90,000
New +$3.08M 0.03% 358

Other funds holding MXIM

CCM
Coldstream Capital Management Bellevue, Washington $7.99B AUM 24.2% 1-Year Est. Return
RP
Rowlandmiller & Partners Atlanta, Georgia $549M AUM 36.2% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

UBS O'Connor's MXIM Position: Q3 2021 in Review

UBS O'Connor sold out of Maxim Integrated Products (MXIM) in Q3 2021, closing a stake of 8,064,116 shares — an estimated $850M sold.

UBS O'Connor first reported a position in MXIM in Q2 2015 and held it in 6 quarters. The position peaked at $850M in Q2 2021. 3 funds tracked by Wall St. Rank hold MXIM as of Q3 2021.

  • UBS O'Connor reported no remaining Maxim Integrated Products position as of Q3 2021 after selling out during the quarter.
  • UBS O'Connor sold 8,064,116 Maxim Integrated Products shares in Q3 2021, an estimated $850M.
  • UBS O'Connor first reported a position in Maxim Integrated Products in Q2 2015 and held it in 6 quarters.
  • UBS O'Connor's Maxim Integrated Products position peaked at $850M in Q2 2021.
  • 3 funds tracked by Wall St. Rank held Maxim Integrated Products as of Q3 2021.

Based on UBS O'Connor's 13F filing for Q3 2021, filed 12 Nov 2021.